Trans1 reported 1Q:09 revenues of $8.7 million, representing an increase of 45% over 1Q:08 and beating estimates by $1.1 million. There were 889 Trans1 procedures performed during the quarter. Net loss widened in 1Q:09 to $5.2 million from $2.4 million on account of higher operating expenses. Adjusted non-GAAP earnings were $0.22 per share, missing estimates by $0.10.
Tweet Share AUSTIN, Texas–(Healthcare Sales & Marketing Network)– Ortho Kinematics‚ a private company focused on...
Tweet Share The latest advancement in expandable cage technology for surgeons, hospitals and patients ...
Tweet Share MEMPHIS, Tenn.–(Healthcare Sales & Marketing Network)– Medtronic, Inc. (NYSE:MDT ) the world leader...
Archive for Product Launch »Archive for Publications »Tweet Share Eden Spine launches in the United States its proprietary Vertebral Body Replacement (VBR),…
Tweet Share IRVINE, Calif., Jan. 31, 2012 /PRNewswire via COMTEX/ — Interventional Spine®, Inc. today…
Tweet Share MINNEAPOLIS–(Healthcare Sales & Marketing Network)– Medtronic, Inc. (NYSE:MDT ) announced today that it…
Archive for FDA »
